MLL1 Minimal Catalytic Complex is a Dynamic Conformational Ensemble Susceptible to Pharmacological Allosteric Disruption

Lilia Kaustov,Alexander Lemak,Hong Wu,Marco Faini,Scott Houliston,Lixin Fan,Xianyang Fang,Hong Zeng,Shili Duan,Abdellah Allali-Hassani,Masoud Vedadi,Ruedi Aebersold,Yunxing Wang,Cheryl H. Arrowsmith
DOI: https://doi.org/10.1101/308676
2018-01-01
Abstract:Histone H3K4 methylation is an epigenetic mark associated with actively transcribed genes. This modification is catalyzed by the mixed lineage leukaemia (MLL) family of histone methyltransferases including MLL1, MLL2, MLL3, MLL4, SET1A and SET1B. Catalytic activity of MLL proteins is dependent on interactions with additional conserved proteins but the structural basis for subunit assembly and the mechanism of regulation is not well understood. We used a hybrid methods approach to study the assembly and biochemical function of the minimally active MLL1 complex (MLL1, WDR5 and RbBP5). A combination of small angle X-ray scattering (SAXS), cross-linking mass spectrometry (XL-MS), NMR spectroscopy, and computational modeling were used to generate a dynamic ensemble model in which subunits are assembled via multiple weak interaction sites. We identified a new interaction site between the MLL1 SET domain and the WD40 repeat domain of RbBP5, and demonstrate the susceptibility of the catalytic function of the complex to disruption of individual interaction sites.
What problem does this paper attempt to address?